Today
L Catterton warms up Quadrant, HPS for Fitness First buy
US private equity investor L Catterton is back for a second crack at Quadrant Private Equity’s gyms roll-up, Street Talk can reveal.
- 39 mins ago
- Sarah Thompson, Kanika Sood and Emma Rapaport
This Month
- Opinion
- Chanticleer
Hospitals are the pain point in the private health sector
NIB boss Mark Fitzgibbon acknowledges private hospitals are under pressure. Tuesday’s rise in health insurance premiums will kick off a new battle.
- James Thomson
Judge slams Chinese state-owned funds trying to seize Nature’s Care
In the NSW Supreme Court, James Stevenson became almost visibly angry after the two funds refused to accept they should be subject to his ruling.
- Aaron Patrick
- Opinion
- Chanticleer
How a little acquisition exposed Healius’ core and has heads rolling
Inbuilt system growth covered the cracks for years. Now there is nowhere to hide and its two-pronged pathology/radiology strategy will be consigned to history.
- Anthony Macdonald
Healius CEO exits as strategic review speeds up
Maxine Jaquet is leaving Australia’s second-largest pathology company, with private equity players likely circling in what may end in a break-up of the company.
- Simon Evans
February
Ramsay Health Care warns of hospital closures as costs blow out
The country’s largest private hospital group said at least 16 rival facilities had shut in the last year and called for more funding from health insurers.
- Simon Evans
- Opinion
- Chanticleer
Ramsay shows belts are tightening on new investments
Ramsay Health Care has lifted its hurdles for new investments. Investors want to see more.
- Anthony Macdonald
Record Point limbers up for Snap Fitness auction
Snap Fitness has 1000 clubs spread across 18 countries and is expected to attract the attention of local private equity groups already invested in the sector.
- Sarah Thompson, Kanika Sood and Emma Rapaport
G8 raises childcare fees as chief executive collects $3m in pay
The Gold Coast-based group, which has more than 400 centres, said the price rise was linked to higher wage and supply costs – although margins could increase.
- Liam Walsh
Healius flags asset sales and plans to shut some operations
But the country’s second-largest pathology group cannot say what assets are being considered for sale after it recorded a collapse in margins since June 30.
- Simon Evans
Five fad diets that won’t work
Instagram and TikTok are fuelling the rise of a new weight loss miracle cure seemingly every week. Here are five you can unfollow immediately.
- Jack Rear
Genesis Capital in Pacific Smiles waiting room as Crescent walks
Street Talk understands said the healthcare-focused private equity firm has walked away after checking out the in-play dental clinic operator.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Healthcare hopeful ADTY calls in potential backers for $50m check-up
A three-page flyer, seen by Street Talk, told interested parties the group has a pipeline of 25 healthcare practices ready for integration.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Ansell cuts almost 1300 jobs as profits keep sliding
The cut represents some 9 per cent of its global workforce. The company has also sliced its dividend payout after profits slumped by 70 per cent.
- Simon Evans
Integral Diagnostics tops PEP Secure Assets Fund’s radiology hit list
PEP’s SAF is far from the first core-plus strategy to get into radiology assets, considered a social infrastructure play.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Cochlear’s big first half delivers record earnings and dividend
The company reported its best interim sales and underlying net profit thanks to strong growth for its core hearing implants and services.
- Ben Potter
- Exclusive
- Healthcare
GenesisCare emerges from bankruptcy, cuts deal with government
The country’s largest cancer treatment group had charged patients for treatment when it was required by the federal government to only bulk bill them.
- Carrie LaFrenz and Jemima Whyte
The juggernaut keeping CSL’s valuation pumping despite Ozempic threat
CSL managed to shrug off the Ozempic effect and this week’s setback linked to a disappointing phase three trial thanks to its CSL Behring blood products business.
- Updated
- Ben Potter
Chris Pyne to chair ageing lobby
COTA Australia has appointed the former ageing minister as its new chairman, replacing career bureaucrat Jane Halton.
- Myriam Robin
Savaged APM hands more cash to UBS
As a joint lead manager and joint bookrunner of the 2021 float, UBS took its share of a $44 million jackpot in listing fees.
- Myriam Robin
